| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/08/1989 | EP0302758A1 Viral expression inhibitors |
| 02/08/1989 | EP0302754A2 Stable aqueous thrombin solution |
| 02/08/1989 | EP0302734A2 Continuous processes for modifying biologically active materials and the products therefrom |
| 02/08/1989 | EP0302582A1 Drug delivery system and method of making the same |
| 02/08/1989 | EP0302473A2 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| 02/08/1989 | EP0302466A1 Cyclopeptides as absorption enhancers for administration on the mucous membranes |
| 02/08/1989 | EP0302456A1 New tissue plasminogen activator |
| 02/08/1989 | EP0302445A2 A novel hypoglycemic and growth-promoting agent |
| 02/08/1989 | EP0302429A1 Novel human interleukin 4, expression vectors for human interleukin 4 and transformants containing the same |
| 02/08/1989 | EP0302407A2 Metallic complexes of streptogramin-B, their preparation and their use in animal food |
| 02/08/1989 | EP0302103A1 Colony stimulating factors having reduced levels of carbohydrate |
| 02/08/1989 | EP0302065A1 Pharmaceutical compositions. |
| 02/08/1989 | EP0169111B1 Cytotoxic conjugates useful in therapy, and process for obtaining them |
| 02/08/1989 | EP0145775B1 A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A $g(g)-INTERFERON CONTAINING PREPARATION |
| 02/08/1989 | EP0125290B1 Peptides affecting gonadal function |
| 02/08/1989 | CN1030917A Immunosuppressant peptides |
| 02/07/1989 | US4803262 Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods |
| 02/07/1989 | US4803167 Hybridoma culture product; treatment for congestive heart failure |
| 02/07/1989 | US4803075 Injectable implant composition having improved intrudability |
| 02/07/1989 | US4803072 Inducing interferon production by administering specific polypeptides; viricides, antitumor agents |
| 02/01/1989 | EP0301970A1 Method for dissolving arginineamides and pharmaceutical compositions containing them |
| 02/01/1989 | EP0301900A2 L'utilisation de riboside ou ribotide de l'AICA pour la fabrication d'un médicament contre la crise cardiaque ou l'infarctus du myocarde aux patients souffrant d'athérosclerosis. |
| 02/01/1989 | EP0301850A2 LHRH antagonist analogs and 19-nor-progestational steroids for therapy |
| 02/01/1989 | EP0301785A2 Carboxamide derivatives of glycopeptides |
| 02/01/1989 | EP0301570A2 Oligopeptides useful for treating AIDS |
| 02/01/1989 | EP0301528A1 Monitoring and warning system for series fed runway visual aids |
| 02/01/1989 | EP0301484A1 PTH modifications and therapeutic compositions containing them or consisting of them |
| 02/01/1989 | EP0301458A2 Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses |
| 02/01/1989 | EP0301392A1 Pharmaceutical composition for intranasal administration comprising GH - Releasing hormone, a cholinergic agonist and in case a bile salt |
| 02/01/1989 | EP0301314A2 A method for the purification of interferon |
| 02/01/1989 | EP0301289A1 Humaner Papillomvirus Typ 41 |
| 02/01/1989 | EP0301247A2 De-mannosyl teicoplanin derivatives |
| 02/01/1989 | EP0301122A1 Use of soybean kunitz type trypsin and derivatives in the preparation of medicaments and agent comprising the same |
| 02/01/1989 | EP0301083A1 Retroviral expression vectors and methods for producing hbv antigens |
| 02/01/1989 | CN1030766A Enkastine-glycopeptide of action having inhibitory encephalinase, process for preparing them and pharamaceutical use |
| 01/31/1989 | US4801689 Isolation from mammalian oxiduct, absorption onto lecithin immobilized on support, then separation |
| 01/31/1989 | US4801685 Microbial production of mature human leukocyte interferon K and L |
| 01/31/1989 | US4801614 Process for using endogenous enkephalins and endorphins to inhibit growth of tumerous cells |
| 01/31/1989 | US4801613 Bradykinin antagonist peptides |
| 01/31/1989 | US4801612 Method of inhibiting inflammatory response |
| 01/31/1989 | US4801609 Mercapto-acylamino acid antihypertensives |
| 01/31/1989 | US4801580 Peptide, process for preparation thereof and use thereof |
| 01/31/1989 | US4801578 Muramylpeptide-glycoprotein immunostimulant derivatives, their preparation and their use in medication |
| 01/31/1989 | US4801577 Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
| 01/31/1989 | US4801576 Polypeptides |
| 01/31/1989 | US4801575 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 01/31/1989 | US4801542 Expression of biologically active PDGF analogs in eucaryotic cells |
| 01/31/1989 | US4801452 Fibrinolytic composition |
| 01/31/1989 | US4801450 High titer pseudomonas immune serum globulin |
| 01/31/1989 | CA1249700A1 Compounds of the muramyl-peptide type and medicaments containing them |
| 01/31/1989 | CA1249699A1 Retro-inverso analogue of the (5-14) decapeptide of equine angiotensinogen, as a specific renin inhibitor with high resistance to enzymatic hydrolysis |
| 01/31/1989 | CA1249698A1 Retro-inverso analogues of c-terminal penta and hexapeptides of substance p |
| 01/26/1989 | WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/26/1989 | WO1989000582A2 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 01/26/1989 | WO1989000581A1 Lectines fixing beta-d-galactoside |
| 01/26/1989 | WO1989000580A1 Superactive human insulin analogues |
| 01/26/1989 | WO1989000428A1 Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus |
| 01/26/1989 | WO1989000427A1 Pharmaceutical therapeutic use of a glutathione derivative |
| 01/26/1989 | WO1989000426A1 Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| 01/26/1989 | WO1989000166A3 Growth hormone related peptide |
| 01/26/1989 | WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof |
| 01/25/1989 | EP0300988A2 Tissue factor inhibitor |
| 01/25/1989 | EP0300982A2 Treatment of infertility |
| 01/25/1989 | EP0300973A1 Physiologically active substances, a process for the preparation thereof and pharmaceutical compositions containing them |
| 01/25/1989 | EP0300878A1 Pharmaceutical compositions for the treatment of uremia |
| 01/25/1989 | EP0300785A2 Cyclosporins |
| 01/25/1989 | EP0300784A2 Peptides |
| 01/25/1989 | EP0300741A2 Human thymopoietin |
| 01/25/1989 | EP0300737A2 Calcitonin gene related peptide derivatives |
| 01/25/1989 | EP0300680A2 Doublestranded RNA correction of abnormalities in circulating immune complexes and monocyte function |
| 01/25/1989 | EP0300675A2 Method for the improvement of cyclosporine therapy |
| 01/25/1989 | EP0300282A1 Pharmaceutical and cosmetic compositions containing complexes of flavanolignans with phospholipids |
| 01/25/1989 | EP0300213A1 Hepatitis a viral peptide particle immunogens |
| 01/25/1989 | EP0300102A1 Improved method of obtaining immune regulatory factors by mammal immunization |
| 01/25/1989 | EP0300036A1 Vasopressin-based pharmaceutical compositions |
| 01/25/1989 | EP0300031A1 Immunosuppressive peptides and methods of use |
| 01/25/1989 | EP0300030A1 Human proteins having anticoagulant and anti-inflammatory activity |
| 01/25/1989 | EP0300021A1 A process for treating infertility and an agent for use in the process. |
| 01/25/1989 | EP0299963A1 Renin inhibitors having a lactam pseudo dipeptide. |
| 01/25/1989 | EP0150350B1 Cross-linked polymers, process for their manufacture and use thereof |
| 01/25/1989 | EP0077826B1 Agents for arresting fulminating infection |
| 01/25/1989 | CN1030609A Protein with 8th activity factor,process for its preparation using genetic engineering cell and pharmaceutical composition containing it |
| 01/25/1989 | CN1030589A Urinary follicle stimulating hormone |
| 01/24/1989 | US4800191 Luteinizing hormone releasing hormone, peptides |
| 01/24/1989 | US4800085 Slow-release composite and process for producing the same |
| 01/24/1989 | US4800081 Calcium influx blocker synergistic with interferon or cyclic nucleotide modulator |
| 01/24/1989 | CA1249399A1 Process for preparing v.sub.1-vasopressin antagonists |
| 01/24/1989 | CA1249398A1 Process for preparing basic v.sub.1-vasopressin antagonists |
| 01/24/1989 | CA1249397A1 Process for preparing des-proline vasopressin antagonists |
| 01/24/1989 | CA1249396A1 Partially retro-inverted decapeptide as a specific renin inhibitor with high resistance to enzymatic hydrolysis |
| 01/24/1989 | CA1249394A1 Compounds for treating hypertension |
| 01/24/1989 | CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 01/19/1989 | EP0281579A4 Cofactor of prourokinase. |
| 01/19/1989 | DE3822557A1 Somatostatins |
| 01/19/1989 | DE3722673A1 DNA coding for plasminogen activator inhibitor type 2 (PAI-2) |
| 01/19/1989 | DE3722647A1 Galenische verwendung eines tripeptids als arzneimittel Pharmaceutical use of a tripeptide as drug |
| 01/19/1989 | DE3710430A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 01/19/1989 | DE3710364A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 01/18/1989 | EP0299828A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications |
| 01/18/1989 | EP0299782A2 Expression vectors for the production of human Granulocyte-Macrophage Colony Stimulation Factor in a mammalian cell host(18.05.92) |